Unity Biotechnology, Inc.

NASDAQ:UBX

1.77 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Revenue 000.2364.7840001.3820
Cost of Revenue 019.6992.182.883.4492.6632.1837.3730.153
Gross Profit 0-19.699-1.9441.904-3.449-2.663-2.18-35.991-0.153
Gross Profit Ratio 00-8.2370.398000-26.0430
Reseach & Development Expenses 13.00620.79936.85938.39367.30970.95758.90737.37313.707
General & Administrative Expenses 15.4618.76620.94923.05624.02520.04616.0169.6175.137
Selling & Marketing Expenses 000000000
SG&A 15.4618.76620.94923.05624.02520.04616.0169.6175.137
Other Expenses 2.705-14.597-0.017-0.9830.1824.185-0.245-0.1030
Operating Expenses 31.17124.96857.80861.44991.33491.00374.92346.9918.844
Operating Income -31.171-44.667-57.572-56.665-93.93-89.651-79.465-45.608-18.844
Operating Income Ratio 00-243.949-11.845000-33.0010
Total Other Income Expenses Net 5.1814.80713.103-4.060.0867.4743.0670.952-11.56
Income Before Tax -25.99-39.86-59.927-60.725-93.844-82.177-76.398-44.656-30.404
Income Before Tax Ratio 00-253.928-12.693000-32.3130
Income Tax Expense 00-2.18-0.686-1.975-7.3043.067-1.05511.56
Net Income -25.99-39.86-57.747-60.039-91.869-74.873-76.398-44.656-30.404
Net Income Ratio 00-244.691-12.55000-32.3130
EPS -1.54-2.7-6.08-10.76-18.06-17.16-27.02-129.91-88.45
EPS Diluted -1.54-2.7-6.08-10.76-18.06-17.16-27.02-129.91-88.45
EBITDA -31.171-37.283-38.731-54.668-89.103-89.651-74.218-44.304-28.068
EBITDA Ratio 00-238.852-12.029000-32.0580